Blood collection devices play a crucial role in the treatment of the patient. blood samples are collected for the treatment to measure the fundamental metabolism components such as magnesium, sodium, chloride, potassium, blood urea nitrogen, and creatinine, and measuring lipid levels and blood glucose. In recent years, as technology has increased in availability and complexity, the experts in the laboratories are receiving a wide range of challenges and opportunities. In case of opportunity, an automated method of collection enables technicians to perform a greater variety of tests on smaller sample quantities with greater accuracy of outcomes than the manual blood collection process.
Get FREE Sample Report with Latest Covid19 Impact Analysis
As a result, a growing number of laboratories are transitioning from hematology and chemical analyzers to automated systems.
Furthermore, rising need for blood donations is fueling the global blood collection devices market growth over the forecast period. For instance, according to World Health Organization (WHO), 112.5 million blood donations were received worldwide, with a rise of 10.7 million blood donations from unpaid donors recorded between 2008 and 2013. Moreover, according to the American Red Cross, around 10,000 units of plasma and 7,000 units of platelets are required daily in the U.S., and nearly 21 million blood components are transmitted in the U.S. each year.
Rising incidence of various medical conditions such as diabetes, anemia, HIV/AIDS, coronary heart disease, and cancer is propelling the global blood collection devices market growth. Furthermore, rising number of operations, as well as the increased demand for blood transfusions and casualty incidents, are propelling the global blood collection devices market growth. According to the Centers for Disease Control and Prevention (CDC), the U.S. recorded 26,203 Lyme disease cases between 2006 and 2016. According to the same source, around 10,265 deaths have been reported in 2015 as a result of alcohol-impaired accidents, accounting for around 29 % of all deaths related to traffic in the U.S.
Ongoing product innovation in blood collection devices is fueling the global blood collection devices market growth during the forecast period.
Tasso, Inc., a manufacturer of HemoLink, a convenient blood collection device used in multiple diagnostic applications, received a US$ 3 million fund from the Defense Advanced Research Projects Agency (DARPA) to develop their HemoLink technology by partnering with GenTegra LLC, a manufacturer of products used in in-vitro diagnostics, biopreservation, and biobanking. Furthermore, ongoing product development and future advancements in blood collection techniques are expected to drive the global blood collection devices market growth during the forecast period.
Get PDF Brochure with Latest Insights
Recent approvals U.S. Food and Drug Administration (FDA) have allowed innovative and technologically advanced blood collection devices to enter the market.
In November 2017, DBS System SA received a USPTO patent for the HemaXis Microfluidic blood collection system. HemaXis DB is a microfluidic blood collection system that involves a microfluidic chip in conjunction with a standard filter card and protective case to provide a practical solution for blood collection procedures.
Seventh Sense Biosystems, Inc. obtained U.S. Food and Drug Administration (FDA) clearance for their novel Touch Activated Phlebotomy (TAP) blood collection device in February 2017. TAP is a new blood collection device that is used for safe and painless blood testing. Furthermore, in October 2017, Ionis Pharmaceuticals, a company focused on the discovery and development of RNA-targeted drugs for serious and orphan diseases, announced a partnership with Seventh Sense Biosystems to assist the development of improved blood collection and diagnostic devices. The partnership allows for the ongoing development of the TAP device for blood testing.
Velano Vascular, Inc., a medical device company that produces needle-free, vascular devices for blood collection, has gained U.S. Food and Drug Administration approval for its updated needle-free blood collection device.
The Velano device is intended to minimize blood collection-related anxiety and pain in patients in the hospital, allowing healthcare personnel to operate in a safer atmosphere. The U.S. Food and Drug Administration (FDA) approved blood collection devices, with their greater acceptance, contribute to the global blood collection devices market future growth.
Major players in operating in the global blood collection devices market are Haemonetics Corporation, NIPRO Medical Corporation, Medtronic plc, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Qiagen, Terumo Medical Corporation, and Bio-Rad Laboratories, Inc.
Purchase This Premium Report To Access Full Information
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Blood Collection Devices Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Blood Collection Devices Industry Impact
Chapter 2 Global Blood Collection Devices Competition by Types, Applications, and Top Regions and Countries
2.1 Global Blood Collection Devices (Volume and Value) by Type
2.3 Global Blood Collection Devices (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Blood Collection Devices Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Blood Collection Devices Market Analysis
Chapter 6 East Asia Blood Collection Devices Market Analysis
Chapter 7 Europe Blood Collection Devices Market Analysis
Chapter 8 South Asia Blood Collection Devices Market Analysis
Chapter 9 Southeast Asia Blood Collection Devices Market Analysis
Chapter 10 Middle East Blood Collection Devices Market Analysis
Chapter 11 Africa Blood Collection Devices Market Analysis
Chapter 12 Oceania Blood Collection Devices Market Analysis
Chapter 13 South America Blood Collection Devices Market Analysis
Chapter 14 Company Profiles and Key Figures in Blood Collection Devices Business
Chapter 15 Global Blood Collection Devices Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027